Treatment for inflammatory bowel disease (IBD) often requires specialized care. While much of IBD care has shifted to the outpatient setting, hospitalizations remain a major site of healthcare utilization and a sizable proportion of patients with inflammatory bowel disease require hospitalization or surgery during their lifetime. In this review, we approach IBD care from the population-level with a specific focus on hospitalization for IBD, including the shifts from inpatient to outpatient care, the balance of emergency and elective hospitalizations, regionalization of specialty IBD care, and contribution of surgery and endoscopy to hospitalized care
The number and proportion of patients with IBD (A), CD (B), and UC (C) visiting ED and AD stratified...
Crohn's disease and ulcerative colitis are lifelong diseases seen predominantly in the developed cou...
BACKGROUND Inflammatory bowel disease (IBD) is a chronic, inflammatory disorder characterised by bot...
Treatment for inflammatory bowel disease (IBD) often requires specialized care. While much of IBD ca...
BackgroundThe use of biologics in inflammatory bowel disease (IBD) has increased recently. However, ...
Copyright © 2013 Junjie Xu et al.This is an open access article distributed under the Creative Commo...
INTRODUCTION: Inflammatory bowel disease (IBD) is a chronic condition, yet the model of care is ofte...
BACKGROUND AND AIMS: Despite recent advances in medical therapies for inflammatory bowel disease [IB...
The incidence and prevalence rates of inf lammatory bowel disease (IBD) have been increasing in East...
Healthcare systems throughout the world continue to face emerging challenges associated with chronic...
The number and proportion of patients with IBD (A), CD (B), and UC (C) treated with biologics strati...
Treatment strategies for Crohn's disease are targeted toward lifelong management. Optimization of ou...
Recently reported trends in hospitalization of children with Inflammatory Bowel Disease (IBD) show i...
Crohn's disease and ulcerative colitis are lifelong diseases seen predominantly in the developed cou...
Not all national health centers include specialized units or clinicians devoted to inflammatory bowe...
The number and proportion of patients with IBD (A), CD (B), and UC (C) visiting ED and AD stratified...
Crohn's disease and ulcerative colitis are lifelong diseases seen predominantly in the developed cou...
BACKGROUND Inflammatory bowel disease (IBD) is a chronic, inflammatory disorder characterised by bot...
Treatment for inflammatory bowel disease (IBD) often requires specialized care. While much of IBD ca...
BackgroundThe use of biologics in inflammatory bowel disease (IBD) has increased recently. However, ...
Copyright © 2013 Junjie Xu et al.This is an open access article distributed under the Creative Commo...
INTRODUCTION: Inflammatory bowel disease (IBD) is a chronic condition, yet the model of care is ofte...
BACKGROUND AND AIMS: Despite recent advances in medical therapies for inflammatory bowel disease [IB...
The incidence and prevalence rates of inf lammatory bowel disease (IBD) have been increasing in East...
Healthcare systems throughout the world continue to face emerging challenges associated with chronic...
The number and proportion of patients with IBD (A), CD (B), and UC (C) treated with biologics strati...
Treatment strategies for Crohn's disease are targeted toward lifelong management. Optimization of ou...
Recently reported trends in hospitalization of children with Inflammatory Bowel Disease (IBD) show i...
Crohn's disease and ulcerative colitis are lifelong diseases seen predominantly in the developed cou...
Not all national health centers include specialized units or clinicians devoted to inflammatory bowe...
The number and proportion of patients with IBD (A), CD (B), and UC (C) visiting ED and AD stratified...
Crohn's disease and ulcerative colitis are lifelong diseases seen predominantly in the developed cou...
BACKGROUND Inflammatory bowel disease (IBD) is a chronic, inflammatory disorder characterised by bot...